PVCT Provectus Biopharmaceuticals - Correlation between Tumor Mutational Burden and Objective Response Rate with Anti–PD-1 or Anti-PD–L - PVCT Provectus Biopharmaceuticals - InvestorVillage
PVCT Provectus Biopharmaceuticals
This is a semi-private group. You are free to browse messages, but you must be a member of this group to post messages. Join This Group

Group: PVCT Provectus Biopharmaceuticals   /  Message Board  /  Read Message

 
 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  4323 of 4353  at  7/11/2019 12:40:39 PM  by

Stringfellow7777


 In response to msg 4317 by  Hombre77
view thread

Re: Correlation between Tumor Mutational Burden and Objective Response Rate with Anti–PD-1 or Anti-PD–L1 Therapy in 27 Tumor Types

 
Guys thanks for all your posts on valuation and buyouts. Great discussion.
 
Just throwing my 2 cents in there, but could it also be a possibility that getting decent data might take at least another 1-2 years at a minimum, and by that time, the tradeable warrants (which will expire in 2020 June),and the rachet warrants expire in 2021, so once those are eliminated, the stock with good data, might rise to a more acceptable share price, say maybe a 1 dollar or 2 dollar a share?
 
Just to be 100% transparent I own the tradeable warrants (I got suckered), sold my 50,000 shares and bought the warrants, so I and others like me would get screwed, but will still be happy for the others who hold shares.
 
Thanks. 
 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 229
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2018 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...